Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History AQST

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics AQST

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Aquestive Therapeutics Inc

AQST
Current price
4.20 USD -0.25 USD (-5.51%)
Last closed 4.37 USD
ISIN US03843E1047
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 417 177 184 USD
Yield for 12 month +38.61 %
1Y
3Y
5Y
10Y
15Y
AQST
21.11.2021 - 28.11.2021

Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; KYNMOBI a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. The company's proprietary pipeline products include Anaphylm, an epinephrine sublingual film, which is in phase 3 clinical trial for the emergency treatment of allergic reactions, including anaphylaxis; and AQST-108, a topical gel that is in phase 2 clinical trial for the treatment of alopecia areata. In addition, it develops PharmFilm technology for patients suffering from certain central nervous system disorders; and Adrenaverse, an epinephrine prodrug platform. The company was incorporated in 2004 and is headquartered in Warren, New Jersey. Address: 30 Technology Drive, Warren, NJ, United States, 07059

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

8.42 USD

P/E Ratio

Dividend Yield

Financials AQST

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures AQST

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+57 561 000 USD

Last Year

+50 583 000 USD

Current Quarter

+8 720 000 USD

Last Quarter

+11 867 000 USD

Current Year

+39 689 000 USD

Last Year

+29 752 000 USD

Current Quarter

+5 068 000 USD

Last Quarter

+7 347 000 USD
EBITDA -40 506 000 USD
Operating Margin TTM -222.08 %
Price to Earnings
Return On Assets TTM -22.21 %
PEG Ratio
Return On Equity TTM
Wall Street Target Price 8.42 USD
Revenue TTM 54 228 000 USD
Book Value -0.61 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -27.70 %
Dividend Yield
Gross Profit TTM 37 093 000 USD
Earnings per share -0.58 USD
Diluted Eps TTM -0.58 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin -100.02 %

Stock Valuation AQST

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 6.82
Price Sales TTM 7.69
Enterprise Value EBITDA -1.81
Price Book MRQ

Technical Indicators AQST

For 52 Weeks

2.12 USD 5.80 USD
50 Day MA 3.21 USD
Shares Short Prior Month 12 003 700
200 Day MA 3.55 USD
Short Ratio 5.96
Shares Short 11 181 713
Short Percent 14.34 %